CKD-induced dysbiosis drives hepatic synthesis and systemic accumulation of indoxyl sulfate, which is proposed to promote carcinogenesis via Aryl Hydrocarbon Receptor (AhR) and Akt signaling, ultimately upregulating <i>c-Myc</i> and <i>EGFR</i>. Here, MYC is linked to chronic kidney disease.